• Thu. Oct 12th, 2023

Interpol Nabs Azerbaijani: Drugs

Avatar photo

ByDavid Brown

Sep 9, 2023
Interpol Nabs Azerbaijani: Drugs
David Brown

On August 16, a citizen from Azerbaijan was apprehended in Vladivostok under the accusation of possessing over 1.2 grams of methamphetamine, according to an announcement from the Department of Internal Affairs of Primorsky Krai.

Evasion, Apprehension, and Syndicate Dismantling: Recent Developments

The incident led to the initiation of a criminal case due to unlawful possession. During the investigation, the individual managed to evade law enforcement and flee the country, prompting Interpol to issue a search warrant.

“Following thorough operational and search efforts conducted by the Criminal Investigation Department and the NCB Interpol branch of the Primorye Department of Internal Affairs, the 32-year-old Azerbaijani citizen’s whereabouts were identified in Vladivostok. Subsequently, he was apprehended,” the agency communicated in a statement via its Telegram channel.

The detained individual is currently held in custody at the remand center of the GUFSIN of the Russian Federation within the region. The department also indicated that arrangements are being made to determine the feasibility of extraditing him to Azerbaijan.

On July 5, during a meeting of the State Anti-Drug Committee, Russian Interior Minister and Police General Vladimir Kolokoltsev disclosed that earlier in the year, law enforcement agencies in Moscow, Kursk, and Orel regions dismantled the operations of a criminal syndicate. The leaders of this association were involved in drug trafficking.

The detained members of the criminal group, according to the Minister of Internal Affairs, had been conducting drug sales through online stores using concealed locations. The organization included couriers employed by one of the illicit online establishments.

 
Avatar photo

David Brown

With years of expertise in the field, i am bring a wealth of knowledge and insights to our platform. Our editor’s extensive research and understanding of the drug landscape ensure that their content is accurate, informative, and engaging.